Columbia Science Review
  • Home
  • About
    • Our Team
  • Blog
  • Events
    • 2022-2023
    • 2021-2022
    • 2020-2021
    • 2019-2020
    • 2018-2019
    • 2017-2018
    • 2016-2017
  • Publications
  • COVID-19 Public Hub
    • Interviews >
      • Biology of COVID-19
      • Public Health
      • Technology & Data
    • Frontline Stories >
      • Healthcare Workers
      • Global Health
      • Volunteer Efforts
    • Resources & Links >
      • FAQ's
      • Resource Hubs
      • Student Opportunities
      • Podcasts & Graphics
      • Mental Health Resources
      • Twitter Feeds
      • BLM Resources
    • Columbia Events >
      • Campus Events
      • CUMC COVID-19 Symposium
      • CSR Events
    • Our Team
  • Contact

First New Antibiotic Discovered in Decades

2/22/2015

0 Comments

 
Picture
By Ian Cohn
Edited by Josephine McGowan

Scientists have long warned of the impending “age of antibiotic resistance.” As doctors use antibiotics more frequently and liberally, the potential for bacteria to develop drug-resistant mutations and transform into “super-bugs” becomes ever higher. At its worst, this means that eventually, we will stand powerless to these drug-resistant super-bugs, no longer able to count on our library of antibiotic weapons which we have relied on so assuredly since Alexander Fleming’s discovery of penicillin in 1929. Though such a prescription seems grim and outlandish, until recently, new antibiotics had not been discovered since 1987, feeding the peripheral fear of a potential new Dark Age that has plagued the imaginations of doctors and medical researchers. However, in January of this year, researchers at Northeastern University provided a much-needed sigh of relief as they announced the discovery of a novel antibiotic, Teixobactin.

Teixobactin, like many other antibiotics, inhibits bacterial cell wall synthesis, but its mechanism of doing so is particularly intriguing. Unlike other antibiotics, Teixobactin works by binding to important components of the cell wall that are common to most bacteria. Because the lipids that are bound by Teixobactin are common across bacterial species, the possibility of a drug-resistant mutation is potentially lower in response to Teixobactin, as it is unlikely that a bacterium can develop a functional substitute to these two important cell wall components.

While the discovery of the new compound itself is important and brings with it the potential for treatment of drug-resistant bacteria, the most exciting part of the recent discovery is not the Teixobactin itself but is in the methodology used to obtain it. Scientists wishing to discover new antibiotics have long been hindered by the need to culture the bacteria that produce the antibiotics in a lab setting.  Often, the bacteria are unable to grow in these unnatural environments. The method used by the researchers at Northeastern, however, mitigates this problem by allowing the bacteria to grow in soil—an environment these bacteria are accustomed to—but still allows for the extraction of potential antibiotic compounds. To accomplish this technique, scientists used a device called the iChip that allows for single bacterial cells to grow in diluted soil. The iChip is placed in a soil sample, providing the bacteria with a more appropriate environment in which to grow than a petri dish, and allowing scientists to keep individual colonies isolated. Once the bacteria begin to grow in in the iChip environment, colonies are isolated and extracted to grow in vitro, where they are able to grow more efficiently since they had somewhat of a “kick-start” in the soil. This novel method can be adapted in the future to grow different bacterial strains that may serve as potential sources for other antibiotics.
​
Despite these promises, letting our “super-bug” guard down completely would be shortsighted and irresponsible. Teixobactin has yet to be tested in humans, and it is possible that it may be too difficult to administer or dysfunctional in human immune systems. In addition, the mechanisms by which bacteria obtain drug-resistance are not fully understood, so there may still be an unknown method through which bacteria become mutated to resist Teixobactin. Nonetheless, the iChip method gives hope in the antibiotic world and provides us with a new pathway to potentially circumvent, or at least stave off, the prophetic age of antibiotic resistance.
0 Comments



Leave a Reply.

    Categories

    All
    Artificial Intelligence
    Halloween 2022
    Winter 2022-2023

    Archives

    April 2024
    January 2024
    February 2023
    November 2022
    October 2022
    June 2022
    January 2022
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    November 2019
    October 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    April 2018
    March 2018
    February 2018
    November 2017
    October 2017
    May 2017
    April 2017
    April 2016
    March 2016
    February 2016
    December 2015
    November 2015
    October 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    May 2014
    April 2014
    March 2014
    February 2014
    December 2013
    November 2013
    October 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    April 2011
    March 2011
    February 2011
    September 2010
    August 2010
    July 2010
    June 2010
    May 2010
    April 2010
    March 2010
    February 2010
    January 2010
    December 2009
    November 2009
    July 2009
    May 2009

Columbia Science Review
© COPYRIGHT 2022. ALL RIGHTS RESERVED.
Photos from driver Photographer, BrevisPhotography, digitalbob8, Rennett Stowe, Kristine Paulus, Tony Webster, CodonAUG, Tony Webster, spurekar, europeanspaceagency, Christoph Scholz, verchmarco, rockindave1, robynmack96, Homedust, The Nutrition Insider
  • Home
  • About
    • Our Team
  • Blog
  • Events
    • 2022-2023
    • 2021-2022
    • 2020-2021
    • 2019-2020
    • 2018-2019
    • 2017-2018
    • 2016-2017
  • Publications
  • COVID-19 Public Hub
    • Interviews >
      • Biology of COVID-19
      • Public Health
      • Technology & Data
    • Frontline Stories >
      • Healthcare Workers
      • Global Health
      • Volunteer Efforts
    • Resources & Links >
      • FAQ's
      • Resource Hubs
      • Student Opportunities
      • Podcasts & Graphics
      • Mental Health Resources
      • Twitter Feeds
      • BLM Resources
    • Columbia Events >
      • Campus Events
      • CUMC COVID-19 Symposium
      • CSR Events
    • Our Team
  • Contact